Australian researchers close in on malaria vaccine

0 comments

SYDNEY: Australian researchers said Tuesday they were closing in on a potential vaccine against malaria, with a study showing their treatment had protected mice against several strains of the disease.

Michael Good, from Queensland’s Griffith University, said the vaccine led  to naturally existing white blood cells, or T-cells, attacking the potentially  deadly malaria parasite which lives in red blood cells.

“A single vaccination induced profound immunity to different malaria  parasite species,” the study, published Tuesday in the Journal of Clinical  Investigation, states.

Good said the team’s research was focused on inducing the white blood cells  to attack the parasite, whatever the malaria strain.

“The T-cells (white blood cells), when they’re induced to kill malaria, can  recognise proteins throughout the parasite, even internal proteins in the  parasite,” he told the ABC.

“So that’s where we think the novel aspect is: we’ve been able to induce a  form of immune response which can recognise molecules in the parasite which are  present in every single strain.”    Good said he believed it was the first time that a vaccine had been shown  to protect against more that two strains of malaria in mice.

The vaccine was expected to be cheap and easy to manufacture, he added,  meaning  that — if applicable to humans — it could have a significant impact  in poor countries where malaria kills thousands each year.

“But we don’t want to get ahead of ourselves; we want to demonstrate, first  and foremost, that the vaccine is effective in humans,” Good told the  broadcaster.

In 2010 an estimated 219 million people were infected with the disease and  some 660,000 died, most of them African children aged under five, the UN’s  World Health Organisation said in December.

A study published in the Lancet in February 2012 said the global death toll  was more likely to be around 1.2 million a year. -- AFP
 


Leave Your Comment


Leave Your Comment:

New Straits Times reserves the right not to publish offensive or abusive comments and those of hate speech, harassment, commercial promos and invasion of privacy. Your IP will be logged and may be used to prevent further submission.The views expressed here are that of the members of the public and unless specifically stated are not those of NST.